Co-Authors
This is a "connection" page, showing publications co-authored by Bani Jolly and Abhinav Jain.
Connection Strength
0.700
-
Analysis of the potential impact of genomic variants in global SARS-CoV-2 genomes on molecular diagnostic assays. Int J Infect Dis. 2021 Jan; 102:460-462.
Score: 0.228
-
Asymptomatic Reinfection in 2 Healthcare Workers From India With Genetically Distinct Severe Acute Respiratory Syndrome Coronavirus 2. Clin Infect Dis. 2021 11 02; 73(9):e2823-e2825.
Score: 0.061
-
An optimized, amplicon-based approach for sequencing of SARS-CoV-2 from patient samples using COVIDSeq assay on Illumina MiSeq sequencing platforms. STAR Protoc. 2021 09 17; 2(3):100755.
Score: 0.060
-
Pharmacogenomic landscape of COVID-19 therapies from Indian population genomes. Pharmacogenomics. 2021 07; 22(10):603-618.
Score: 0.059
-
Genomic survey of SARS-CoV-2 vaccine breakthrough infections in healthcare workers from Kerala, India. J Infect. 2021 08; 83(2):237-279.
Score: 0.059
-
Symptomatic reinfection of SARS-CoV-2 with spike protein variant N440K associated with immune escape. J Med Virol. 2021 07; 93(7):4163-4165.
Score: 0.059
-
Initial Insights Into the Genetic Epidemiology of SARS-CoV-2 Isolates From Kerala Suggest Local Spread From Limited Introductions. Front Genet. 2021; 12:630542.
Score: 0.058
-
High throughput detection and genetic epidemiology of SARS-CoV-2 using COVIDSeq next-generation sequencing. PLoS One. 2021; 16(2):e0247115.
Score: 0.058
-
Asymptomatic reactivation of SARS-CoV-2 in a child with neuroblastoma characterised by whole genome sequencing. IDCases. 2021; 23:e01018.
Score: 0.057